Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Derivation of An In-Hospital Cardiac Arrest Prediction Model for Patients in Intensive Care Unit

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04670458
Recruitment Status : Recruiting
First Posted : December 17, 2020
Last Update Posted : December 17, 2020
Sponsor:
Information provided by (Responsible Party):
Qilu Hospital of Shandong University

Brief Summary:
Current studies have shown that hospitalized ICU patients have a high risk of IHCA, with an incidence of about 0.6-7.8%. Early prediction of the occurrence of IHCA in severe patients can provide early intervention, prevent the deterioration of the disease, and reduce the incidence of IHCA. Therefore, researchers wanted to verify the efficacy of MEWS, NEWS, and CART scores in predicting IHCA in ICU inpatients, and to establish an early-warning scoring model that could effectively predict the risk of IHCA occurrence in ICU inpatients during hospitalization.

Condition or disease Intervention/treatment
In-Hospital Cardiac Arrest Other: no intervention

Layout table for study information
Study Type : Observational
Estimated Enrollment : 2000 participants
Observational Model: Case-Control
Time Perspective: Retrospective
Official Title: Derivation of An In-Hospital Cardiac Arrest Prediction Model for Patients in Intensive Care Unit
Actual Study Start Date : October 1, 2020
Estimated Primary Completion Date : September 30, 2021
Estimated Study Completion Date : December 31, 2021

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
CA group
Patients with In-Hospital Cardiac Arrest
Other: no intervention
no intervention

CONTROL group
Patients without In-Hospital Cardiac Arrest
Other: no intervention
no intervention




Primary Outcome Measures :
  1. In-Hospital Cardiac Arrest [ Time Frame: Day 2 ]
    Cardiac arrest occurs during hospitalization



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   14 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients hospitalized in the intensive care unit (ICU, CCU, RICU, EICU, NCU and DICU) of Qilu Hospital of Shandong University from January 1, 2017 to October 31, 2019 were selected.
Criteria

CA group

Inclusion Criteria:

  • Occurrence of IHCA
  • Hospital stay ≥48h.

Exclusion Criteria:

  • <14 years
  • Do Not Resuscitat
  • Patients hospitalized due to out-of-hospital cardiac arrest
  • Cardiac arrest occurs during the operation
  • The patients with implanted cardiac pacemaker suffered cardiac arrest due to instrument malfunction.

CONTROL group

Inclusion Criteria:

  • Without IHCA
  • Hospital stay ≥48h

Exclusion Criteria:

  • <14 years
  • Leave hospital without medical advice

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04670458


Contacts
Layout table for location contacts
Contact: Wentao Sang 15153187102 752318151@qq.com
Contact: Feng Xu 18560083066 xufengsdu@126.com

Locations
Layout table for location information
China, Shandong
Qilu Hospital of Shandong University Recruiting
Jinan, Shandong, China, 250012
Contact: Wentao Sang    15153187102    752318151@qq.com   
Contact: Feng Xu    18560083066    xufengsdu@126.com   
Sponsors and Collaborators
Qilu Hospital of Shandong University
Layout table for additonal information
Responsible Party: Qilu Hospital of Shandong University
ClinicalTrials.gov Identifier: NCT04670458    
Other Study ID Numbers: IHCA-EWS-QLH
First Posted: December 17, 2020    Key Record Dates
Last Update Posted: December 17, 2020
Last Verified: December 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Qilu Hospital of Shandong University:
Critically ill patients
In-Hospital Cardiac Arrest
Early recognition
Early warning score
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Arrest
Heart Diseases
Cardiovascular Diseases